Core Insights - The report by KPMG highlights the rapid growth period of the "AI + Healthcare" sector in China from 2020 to 2021, with the number of financing rounds reaching 280 and total financing exceeding 40 billion yuan, indicating significant demand for digitalization and intelligence in healthcare [1] - From 2023 to 2024, investment and financing in the "AI + Healthcare" sector are expected to decline and stabilize, marking a transition from "wild growth" to "refined cultivation" [1] - AI has made breakthroughs in various fields such as computer vision, natural language processing, and robotics, with significant applications in drug development, enhancing precision medicine by improving gene editing accuracy from 85% to over 98% [1] Investment Trends - The report indicates a decrease in investment activity in the "AI + Healthcare" sector, suggesting a shift towards more sustainable and strategic growth approaches [1] - The integration of AI with technologies like 5G and big data is creating new research directions and treatment methods, with emerging fields such as AI drug development and traditional Chinese medicine innovation gaining traction [2] Challenges and Governance - AI in healthcare faces stringent challenges due to the sensitivity of medical data, irreversible decision outcomes, and complex responsibility attribution, necessitating a focus on "human-machine alignment" [2] - "Human-machine alignment" involves ensuring that AI's logic aligns with human medical standards and societal values through mechanisms like algorithm transparency and ethical constraints [2] - The future development of "AI + Healthcare" will depend not only on computational power and data scale but also on companies' strategic capabilities in compliance design and interdisciplinary integration [2] Policy and Support - The Chinese biotechnology sector is receiving systematic support driven by policy, focusing on collaborative innovation across the entire value chain, capital ecosystem restructuring, expedited review processes, and payment mechanism reforms [2]